A group of pharmaceutical machine enterprises to promote the resumption of production, "intelligent manufacturing" pace or speed up

Pharmaceutical Network Market Analysis: Staff shortage is one of the challenges facing pharmaceutical machine companies to resume productionHowever, the author also noted that in recent years, with the rapid development of automation, information technology and other technologies, many enterprises in the field of automation has achieved certain resultsDuring the outbreak, these companies used "intelligent manufacturing" to promote the resumption of production more smoothly, effectively solving the problem of staff shortageAt the same time, in the medium and long term, the pharmaceutical equipment industry"'s "intelligent manufacturing" upgrade pace or accelerate
A group of pharmaceutical machine enterprises to promote the resumption of production Is learned that the main pharmaceutical equipment manufacturing Chutian more than 400 employees returned to work on February 10, and on February 20 to start a full-scale resumption of work, to provide pharmaceutical companies with much-needed equipment, accessories; The company expects a bigger increase in order and delivery targets this year
At present, Chutian's pharmaceutical robots and smart medicine factories are advancingIt is reported that its intelligent robots will form a rich product line, such as loading robots, filling robots, weighing robots, testing robots and other pharmaceutical production robots, the formation of a complete production system will support high efficiency, high-quality pharmaceutical production, but also for pharmaceutical companies to save costsRecently, the company also said on the interactive platform, the company has provided some customers with the overall solution of the pharmaceutical smart factory
Unusually, Dong Fulong said on the interactive platform on February 24that that the company had fully resumed work on February 10, and that the current resumption rate was about 80%It is reported that during the outbreak, the company disinfection robot supresand robot soutings the current market demand, the order intention is manyAccording to Dongfulong's previous plan, the company will gradually lead the pharmaceutical industry to a highly intelligent big data management, supply chain construction, intelligent manufacturing, sales of the combination of industry 4.0
On February 19th, Canaan Technology officially resumed productionThe company plans to launch the "OEB5 high-confined mitochondrial solution" this year and further expand production through the "C-M Digital Factory"At the same time, further improve the digital factory sub-systems, through intelligent factories to promote the competitiveness of enterprises
It is reported that "C-M digital factory" is cannane technology according to the situation of the enterprise's own new concept, the use of big data platform to collect information and track the project process, from the management to change the traditional workshop process, to achieve the intelligence of the entire plantThe use of this digital factory can improve the efficiency of the operation of the workshop, while making the management more standardized
In the future, the pace of "intelligent manufacturing" or accelerate in recent years, under the "Made in China 2025" and a series of policies, pharmaceutical equipment companies represented by leading enterprises are moving towards "unmanned, less humanized, intelligent" direction, aimed at promoting the development of China's pharmaceutical industry, and promoting the pharmaceutical equipment industry intelligent upgrading During the outbreak, highly automated, intelligent equipment and production lines played a unique advantage, with the rapid development of the pharmaceutical industry and favorable policies in the future, upstream pharmaceutical equipment market development space is also very broad
Industry pointed out that "intelligent manufacturing" is an important direction for the future development of manufacturing enterprises, with the market of domestic automation, intelligent machine equipment, as well as the emergence of fully automated production lines, will help the pharmaceutical industry development, improve production efficiency, reduce corporate costs
And to achieve intelligent manufacturing, the key is data However, from the current overall situation, the current stage of domestic enterpriseautomation, information technology and digital basis is still weak In the future, with the continuous penetration of 5G technology, the intelligent manufacturing upgrade of pharmaceutical enterprises may accelerate.